![]() |
Professor Bernie Tuch Bernie Tuch is the (Founding) Chairman of the NSW Stem Cell Network, a practising endocrinologist, and a Professor of Medicine. Previously, he and colleagues at the Prince of Wales Hospital conducted a clinical trial with encapsulated pancreatic islets as a possible therapy for type 1 diabetes. He is now wishing to carry out a similar trial using insulin-producing cells derived from human embryonic stem cells, that are seeded into a bioengineered device before implantation to overcome the need for recipients to take anti-rejection drugs. To achieve this goal, he works in both academia and industry, with both not-for-profit and for-profit companies. Separately, he is the Acting Chairman of the ASX listed biotechnology company Living Cell Technologies Ltd. |
|
|
Joanna Knott |
|
![]() |
Prof Ian Kerridge Ian Kerridge is Professor of Bioethics and Medicine at Sydney health Ethics in the Faculty of Medicine and Health at the University of Sydney and Staff Haematologist/Bone Marrow Transplant physician at Royal North Shore Hospital, Sydney. He is Chair of the South Eastern Sydney LHD Clinical Ethics Committee and a member of the NSW Health Department's Health Ethics Advisory Panel. In 2005 Ian was a member of the Legislation Review Committee (Lockhart Committee) which reviewed the Prohibition of Human Cloning Act 2002 and the Research Involving Human Embryos Act 2002. |
|
|
Dr Michael Morris |
|
|
Dr Rachel Shparberg |
|
|
Dr Margret Schuller |
|
Past Board Members
|
Dr Kelvin Hopper
Dr Daniella Goldberg
Daniella is on the advisory board of the NSW Stem Cell Network and was the initial manager and co-founder of the NSW Stem Cell Network over 15 years ago.
She is passionate about health & life sciences, innovation, commercialisation, business & start-ups. Daniella has been working with start up biotechnology companies specialising in stem cell therapeutics and is currently an MBA candidate. Prior to this, she worked in science communication and marketing, in TV, radio and print media, turning science into a compelling story for a wide range of audiences including executives, investors, scientific peers, school students, Government and the general public. To balance her professional career in life science start-ups, Daniella created her own boutique wellness business that facilitates high performers to de stress through mindfulness & yoga
in nature.
|
|
|